|
Volumn 12, Issue 4, 1999, Pages 169-177
|
Selective inhibitors of COX-2. New therapeutic agents
a a a a |
Author keywords
Celecoxib; COX 2 inhibitors; Cyclooxygenase; NSAIDs; Prostaglandins; Rofecoxib
|
Indexed keywords
5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE;
5 BROMO 2 (4 FLUOROPHENYL) 3 (4 METHYLSULFONYLPHENYL)THIOPHENE;
6 (2,4 DIFLUOROPHENYLTHIO) 5 METHANESULFONAMIDO 1 INDANONE;
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
CELECOXIB;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
FLOSULIDE;
ISOENZYME;
N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;
NEW DRUG;
NIMESULIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROSTAGLANDIN;
ROFECOXIB;
ABDOMINAL PAIN;
ANALGESIA;
ANIMAL MODEL;
ARTHRITIS;
CATALYSIS;
CONSTIPATION;
DEFENSE MECHANISM;
DIARRHEA;
DRUG SAFETY;
DRUG SELECTIVITY;
DRUG TOLERABILITY;
DUODENUM MUCOSA;
DUODENUM ULCER;
DYSPEPSIA;
ENZYME INHIBITION;
GASTROINTESTINAL DISEASE;
GASTROINTESTINAL HEMORRHAGE;
GASTROINTESTINAL TOXICITY;
HEARTBURN;
HUMAN;
INFLAMMATORY DISEASE;
NAUSEA;
NONHUMAN;
OSTEOARTHRITIS;
PRIORITY JOURNAL;
REVIEW;
STOMACH OBSTRUCTION;
THROMBOCYTE AGGREGATION;
ULCER PERFORATION;
|
EID: 0033451094
PISSN: 09505911
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (6)
|
References (109)
|